Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
12.30
+0.05 (0.41%)
Dec 2, 2025, 4:00 PM EST - Market closed
Embecta Employees
Embecta had 1,850 employees as of September 30, 2025. The number of employees decreased by 250 or -11.90% compared to the previous year.
Employees
1,850
Change (1Y)
-250
Growth (1Y)
-11.90%
Revenue / Employee
$584,000
Profits / Employee
$51,568
Market Cap
719.71M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 1,850 | -250 | -11.90% |
| Sep 30, 2024 | 2,100 | -100 | -4.55% |
| Sep 30, 2023 | 2,200 | 300 | 15.79% |
| Sep 30, 2022 | 1,900 | -129 | -6.36% |
| Sep 30, 2021 | 2,029 | -298 | -12.81% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EMBC News
- 3 days ago - Embecta Growth Stalls Despite Strong Fiscal 2025 Results (Rating Downgrade) - Seeking Alpha
- 6 days ago - Meet 33 Ideal "Safer" November Small/MidCap Value DiviBuys Of The S&P600 - Seeking Alpha
- 7 days ago - Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance - GlobeNewsWire
- 8 days ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 15 days ago - embecta announces changes to Board of Directors - GlobeNewsWire
- 19 days ago - embecta Announces Major New Commitment to Direct Relief on World Diabetes Day - GlobeNewsWire
- 21 days ago - embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire